Unknown

Dataset Information

0

Epigenetic aging in patients diagnosed with coronary artery disease: results of the LipidCardio study.


ABSTRACT:

Introduction

People age biologically at different rates. Epigenetic clock-derived DNA methylation age acceleration (DNAmAA) is among the most promising markers proposed to assess the interindividual differences in biological age. Further research is needed to evaluate the characteristics of the different epigenetic clock biomarkers available with respect to the health domains they reflect best.

Methods

In this study, we have analyzed 779 participants of the LipidCardio study (mean chronological age 69.9 ± 11.0 years, 30.6% women) who underwent diagnostic angiography at the Charité University Hospital in Berlin, Germany. DNA methylation age (DNAm age) was measured by methylation-sensitive single nucleotide primer extension (MS-SNuPE) and calculated with the 7-CpG clock. We compared the biological age as assessed as DNAmAA of participants with an angiographically confirmed coronary artery disease (CAD, n = 554) with participants with lumen reduction of 50% or less (n = 90) and patients with a normal angiogram (n = 135).

Results

Participants with a confirmed CAD had on average a 2.5-year higher DNAmAA than patients with a normal angiogram. This association did not persist after adjustment for sex in a logistic regression analysis. High-density lipoprotein, low-density lipoprotein, triglycerides, lipoprotein (a), estimated glomerular filtration rate, physical activity, BMI, alcohol consumption, and smoking were not associated with DNAmAA.

Conclusion

The association between higher DNAmAA and angiographically confirmed CAD seems to be mainly driven by sex.

SUBMITTER: Banszerus VL 

PROVIDER: S-EPMC9887837 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epigenetic aging in patients diagnosed with coronary artery disease: results of the LipidCardio study.

Banszerus Verena Laura VL   König Maximilian M   Landmesser Ulf U   Vetter Valentin Max VM   Demuth Ilja I  

Clinical epigenetics 20230131 1


<h4>Introduction</h4>People age biologically at different rates. Epigenetic clock-derived DNA methylation age acceleration (DNAmAA) is among the most promising markers proposed to assess the interindividual differences in biological age. Further research is needed to evaluate the characteristics of the different epigenetic clock biomarkers available with respect to the health domains they reflect best.<h4>Methods</h4>In this study, we have analyzed 779 participants of the LipidCardio study (mean  ...[more]

Similar Datasets

2015-06-05 | E-GEOD-69587 | biostudies-arrayexpress
2015-05-05 | E-GEOD-68506 | biostudies-arrayexpress
2015-05-05 | GSE68506 | GEO
2015-06-05 | GSE69587 | GEO
2005-06-30 | GSE2143 | GEO
| S-EPMC1289285 | biostudies-literature
2010-05-16 | E-GEOD-19590 | biostudies-arrayexpress
2012-11-30 | E-GEOD-34822 | biostudies-arrayexpress
2010-01-06 | GSE19590 | GEO
2012-11-30 | GSE34822 | GEO